0 items USD 0.00Search
Your search for "globaldata relapsed chronic lymphocytic leukemia cll global clinical trials review h1 2018" gave back 688391 results.
The global Hematologic Malignancies Treatment market size was valued at USD 55000 million in 2023 and is forecast to a readjusted size of USD 221510...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Hairy Cell Leukemia Drugs market size was valued at US$ 160.6 million in 2023. With growing demand in downstream market, the Hairy Cell...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Bromodomain Containing Protein 4 market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Chronic Myelogenous Leukemia Treatment market size was valued at US$ 4399.9 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The full name of BET inhibitor is BET protein family inhibitor, which refers to drugs that can inhibit BET protein family isomers such as BRDT, BRD2...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Hematologic Malignancies Treatment market size was valued at US$ 52290 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hematological malignancy, also known as hematological disease, is a type of cancer impacting bone marrow, blood, and lymph nodes. Different sorts of...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Leukemia Therapeutics market was valued at US$ 10920 million in 2023 and is anticipated to reach US$ 12890 million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A molecular approach for diagnosing leukemia The global Leukemia Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Acute Myeloid Leukemia (AML) Therapeutics market was valued at US$ 543.8 million in 2023 and is anticipated to reach US$ 1145.5 million by...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
